bioRxiv Science⌕ Search

Biology subjects

Lefranc, M.

Publications and source records attributed to Lefranc, M..

3 recordsLinked to original sources

A minimal activator-inhibitor-repressor model to describe the hepatic circadian clock

Circadian clocks rely on gene regulation networks which generate periodic biochemical oscillations informing our cells about the time of the day. Mathematical modeling has been effective to describe the dynamics of the multiple intertwined feedback loops making up circadian clocks, however it is often delicate to adapt the complexity of the model to the question addressed and to the data available. Traditionally, two main modeling approaches have been followed, using either comprehensive models recapitulating most molecular actors involved, or minimal qualitative models highlighting the core mechanisms. However, analyzing the behavior of large models may be difficult, and small models often lack predictive power, questioning their relevance. Through a systematic reduction of a more complex model, we obtain a simple three-gene clock model, featuring the activator Bmal1, the repressor Reverb and the inhibitor Cry, that accurately describes the corresponding temporal expression profiles for the mouse hepatic clock. We characterize this model by carrying out a sensitivity analysis for its limit cycle, as well as by computing phase response curves for the different possible inputs. Predictions from the model are compatible with a number of synchronizing mechanisms from the literature. SIGNIFICANCELiving systems adapt to the day/night cycle thanks to cellular clocks, which track the time of the day and orchestrate physiological processes throughout the 24 hours. The dynamics of these clocks is complex, due to the interaction of intertwined feedback loops generating the biochemical oscillations and ensuring their synchronization. Mathematical modeling has proved useful to unravel this complexity, however there is usually a difficult choice to be made between comprehensive and minimal models, with opposite strengths and weaknesses. Here, we propose a simple activator-inhibitor-repressor model reproducing surprinsingly well experimental data from mouse livers, whose analysis casts light on the roles of the main actors of the mammalian circadian clock.

systems biology↗

Characterization of a Novel FKS1 Mutation in Candida lusitaniae Shows a Potential Critical Role for MKC1 in Echinocandin Resistance

Caspofungin is an echinocandin antifungal that inhibits glucan synthesis in the fungal cell wall. A Candida parapsilosis bloodstream isolate resistant to echinocandins was recovered from a patient who had undergone allogeneic hematopoietic stem cell transplantation. The FKS1 gene, encoding the target glucan synthase, contained a heterozygous mutation resulting in an I1380T amino acid change, in addition to the naturally occurring P660A polymorphism. When expressed at the equivalent position in the Fks1p protein of C. lusitaniae, P642A and I1359T, alone and in combination, led to 6-, 12-, and [≥]256-fold increases in the minimal inhibitory concentration (MIC) of caspofungin, respectively. The caspofungin concentration needed to inhibit 50% of glucan synthase activity was increased 3-, 37-, and 270-fold, respectively. At high drug concentrations, and also in drug-free medium, infrared spectroscopy revealed a decrease in {beta}-glucan content and an increase in chitin in the cell wall of the I1359T Fks1p mutants. Atomic force microscopy showed cell wall damage and cell swelling in both susceptible and resistant strains under caspofungin exposure. Analysis of susceptibility to cell-wall stressors and key factors in cell wall integrity (CWI) and high-osmolarity glycerol (HOG) pathways showed that all strains activated these pathways under caspofungin stress. In the I1359T Fks1p mutants, Mkc1p was constitutively activated even without caspofungin. Deletion of MKC1 restored caspofungin susceptibility, indicating that activation of the CWI pathway is a key molecular determinant of resistance in vitro to caspofungin in these mutants.

microbiology↗

Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro

ObjectivesCaspofungin is an echinocandin antifungal agent that inhibits synthesis of glucan required for the fungal cell wall. Resistance is mediated by mutation of Fks1 glucan synthase, among which S645P is the most common resistance-associated polymorphism. Rapamycin is a macrolide that inhibits the mechanistic target of rapamycin (mTOR) protein kinase activity. This study investigated the interaction between rapamycin and caspofungin in inhibiting the growth of wild type Candida albicans and Fks1 S645P mutant clinical isolate and wild type Candida lusitaniae and genetically engineered isogenic strain with Fks1 S645P mutation at equivalent position. MethodsInteractions between caspofungin and rapamycin were evaluated using the microdilution checkerboard method in liquid medium. The results were analysed using the fractional inhibitory concentration (FIC) index and the response surface (RS) analysis according to the Bliss model. ResultsSynergy between rapamycin and caspofungin was shown for C. albicans and C. lusitaniae strains by RS analysis of the checkerboard tests. Synergy was observed in strains sensitive and resistant to caspofungin. Weak subinhibitory concentrations of rapamycin were sufficient to restore caspofungin susceptibility. ConclusionsWe report here for the first time synergy between caspofungin and rapamycin in Candida species. Synergy was shown for strains susceptible and resistant to caspofungin. This study highlights the role of the TOR pathway in sensing antifungal-mediated cell wall stress and in modulating the cellular response to echinocandins in Candida yeasts.

microbiology↗